Neuroanatomy Practice Questions

Q: In Prader-Willi syndrome, which of the following is increased?

Ghrelin. **Explanation:** **Prader-Willi Syndrome (PWS)** is a complex genetic disorder caused by the loss of function of genes on the paternal chromosome **15q11-q13**. The hallmark of the syndrome is severe hyperphagia (uncontrollable hunger) leading to morbid obesity. **Why Ghrelin is Increased:** Ghrelin is an "orexigenic" (appetite-stimulating) hormone produced primarily by the P/D1 cells of the stomach. In PWS, there is a characteristic **elevation of circulating Ghrelin levels** (hyperghrelinemia) even before the onset of obesity [1]. This elevation is thought to be a primary driver of the persistent hunger and lack of satiety seen in these patients. Unlike simple obesity where ghrelin is usually suppressed, in PWS, it remains high, making it a high-yield diagnostic marker. **Why Other Options are Incorrect:** * **LH & FSH (Options A & B):** PWS is associated with **Hypogonadotropic Hypogonadism** due to hypothalamic dysfunction. Therefore, levels of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) are typically **decreased**, leading to genital hypoplasia and delayed puberty. * **TSH (Option C):** Central hypothyroidism can occur in PWS due to hypothalamic-pituitary axis dysfunction, meaning **TSH** levels are usually **low or inappropriately normal**, but not increased. **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Paternal deletion of 15q11-q13 (most common) or Maternal Uniparental Disomy (UPD). * **Infancy:** Characterized by severe **hypotonia** ("floppy baby") and feeding difficulties. * **Childhood:** Transition to hyperphagia, obesity, short stature, and small hands/feet. * **Key Association:** High Ghrelin + Low GnRH (leading to low LH/FSH).

Q: Haversian system is seen in which type of bone tissue?

Cortical bone. The **Haversian system**, also known as an **Osteon**, is the fundamental functional unit of **compact (cortical) bone**. It consists of a central Haversian canal containing blood vessels and nerves, surrounded by concentric layers of mineralized matrix called lamellae [2]. Between these lamellae are lacunae containing osteocytes, which communicate via tiny channels called canaliculi. This dense, organized arrangement provides the structural strength required for the outer shell of long bones [1]. **Analysis of Options:** * **Cortical bone (Correct):** This is the dense outer layer of bone where Haversian systems are tightly packed to withstand mechanical stress [1]. * **Cancellous bone (Incorrect):** Also known as spongy or trabecular bone, it lacks true Haversian systems. Instead, it is composed of an irregular lattice of **trabeculae** [1]. Nutrients are absorbed via diffusion from the surrounding bone marrow spaces. * **Teeth (Incorrect):** While teeth contain mineralized tissues (enamel, dentin, cementum), they do not possess Haversian systems. Dentin contains "dentinal tubules," which are structurally distinct. * **Nail (Incorrect):** Nails are composed of hard **keratin** (a protein), not mineralized bone tissue, and thus have no cellular or vascular organization resembling an osteon. **High-Yield Clinical Pearls for NEET-PG:** * **Volkmann’s Canals:** These are horizontal canals that connect adjacent Haversian systems and carry blood vessels from the periosteum. * **Interstitial Lamellae:** These are the remnants of old Haversian systems found between intact osteons, representing the result of continuous bone remodeling. * **Woven Bone:** This is immature bone where collagen fibers are randomly arranged; it lacks Haversian systems and is seen during fetal development or fracture healing [2].

Q: Which of the following is NOT a cyanotic heart disease?

Patent Ductus Arteriosus (PDA). ### Explanation Congenital heart diseases (CHD) are broadly classified into **Cyanotic** (Right-to-Left shunt) and **Acyanotic** (Left-to-Right shunt) [1]. **Why Patent Ductus Arteriosus (PDA) is the correct answer:** PDA is an **acyanotic** heart disease. It involves a persistent communication between the descending aorta and the pulmonary artery [1]. Since the pressure in the aorta is higher than in the pulmonary artery, blood shunts from **Left to Right**. This results in increased pulmonary blood flow but does not cause systemic deoxygenation (cyanosis) initially [1]. **Analysis of Incorrect Options:** * **Tetralogy of Fallot (TOF):** The most common cyanotic CHD after infancy [1]. It involves pulmonary stenosis and a VSD, leading to a **Right-to-Left shunt** and systemic cyanosis. * **Tricuspid Atresia:** A cyanotic condition where the tricuspid valve fails to develop. Systemic venous blood must pass through an ASD to the left side to reach the lungs via a VSD or PDA, resulting in obligatory mixing and cyanosis. * **Eisenmenger’s Complex:** This occurs when a long-standing acyanotic shunt (like VSD or PDA) causes pulmonary hypertension, eventually **reversing the shunt** from Left-to-Right to **Right-to-Left**, thereby causing "tardive" or late-onset cyanosis. **NEET-PG High-Yield Pearls:** * **The 5 T’s of Cyanotic CHD:** **T**OF, **T**ransposition of Great Arteries (TGA), **T**ricuspid Atresia, **T**otal Anomalous Pulmonary Venous Return (TAPVR), and **T**runcus Arteriosus. * **PDA Murmur:** Characterized by a **machinery-type continuous murmur**, loudest at the left infraclavicular area. * **Drug of Choice:** **Indomethacin** or Ibuprofen (NSAIDs) are used to close a PDA in neonates, while **Prostaglandin E1** is used to keep it open in ductal-dependent lesions.

Q: Phase 2 of damage control surgery typically occurs during which phase of patient management?

Resuscitation in the ICU. **Explanation:** Damage Control Surgery (DCS) is a staged surgical strategy designed to manage patients with severe physiological derangement (the "Lethal Triad" of acidosis, hypothermia, and coagulopathy). It prioritizes physiological restoration over anatomical completeness [1]. **1. Why the Correct Answer is Right:** **Phase 2 (ICU Resuscitation)** is the "physiological cooling-off" period. Once the initial surgery (Phase 1) has achieved hemorrhage and contamination control, the patient is transferred to the ICU. The primary goals here are **rewarming, correction of coagulopathy, and hemodynamic stabilization** using advanced monitoring and massive transfusion protocols. This phase typically lasts 24 to 48 hours. **2. Analysis of Incorrect Options:** * **Option A (Pre-hospital):** This is often referred to as "Phase 0." It involves rapid transport and "scoop and run" tactics but is not part of the formal surgical phases. * **Option C (Resuscitation in the OR):** This is **Phase 1**. The focus is on immediate life-saving maneuvers: laparotomy, control of bleeding (packing/shunting), and control of contamination [1]. Definitive repairs are deferred. * **Option D (Definitive Repair):** This is **Phase 3**. Once the patient’s physiology is normalized in the ICU, they return to the OR for pack removal and definitive repair of injuries. **High-Yield Clinical Pearls for NEET-PG:** * **The Lethal Triad:** Hypothermia, Acidosis, and Coagulopathy. DCS aims to break this cycle. * **Phase 1 Goal:** "Get in, get out." Surgery should ideally be completed within 60–90 minutes. * **Abdominal Compartment Syndrome:** A common complication to monitor during Phase 2 due to aggressive fluid resuscitation and temporary abdominal closure [2]. * **Phase 4:** Some classifications include a Phase 4, which involves formal abdominal wall closure.

Q: Memory T cells can be identified by using which of the following markers?

CD45RO. The identification of T cell subsets relies on the expression of different isoforms of CD45 (Leukocyte Common Antigen), a tyrosine phosphatase essential for T-cell receptor signaling. **Why CD45RO is correct:** CD45RO is the shortest isoform of the CD45 molecule. It is characteristically expressed on **Memory T cells** (both CD4+ and CD8+). When a naive T cell encounters an antigen and becomes activated, it undergoes alternative splicing of the CD45 gene, switching from the expression of high-molecular-weight isoforms (like RA) to the low-molecular-weight **CD45RO** isoform. This marker remains on the cell surface, allowing these cells to respond more rapidly upon re-exposure to the same antigen. **Analysis of Incorrect Options:** * **CD45RA:** This is the marker for **Naive T cells** (cells that have not yet encountered their specific antigen). * **CD45RB:** This isoform is typically expressed on B cells, naive T cells, and a subset of memory cells, but it is not a specific diagnostic marker for memory T cells in the context of competitive exams. * **CD45RC:** This is primarily expressed on B cells and specific subsets of CD8+ T cells; it is not the hallmark of memory T cells. **High-Yield Clinical Pearls for NEET-PG:** * **CD45 (LCA):** Used in immunohistochemistry to differentiate lymphomas (CD45 positive) from carcinomas (CD45 negative). * **Memory T-cell subtypes:** * *Central Memory T cells (Tcm):* Express **CCR7** and L-selectin (CD62L); they home to lymph nodes. * *Effector Memory T cells (Tem):* Lack CCR7; they home to peripheral tissues. * **Mnemonic:** "R**A** is for **A**mateur (Naive), R**O** is for **O**ld (Memory)."

Q: Which of the following conditions is associated with HLA-B27 in 90% of cases?

Ankylosing spondylitis. The association between Human Leukocyte Antigen (HLA) alleles and specific diseases is a high-yield topic for NEET-PG. **Ankylosing Spondylitis (AS)** shows the strongest association with **HLA-B27**, with approximately **90-95%** of patients testing positive for this marker [1]. AS is a chronic inflammatory arthritis primarily affecting the sacroiliac joints and the axial skeleton, leading to characteristic "bamboo spine" on imaging. **Analysis of Options:** * **Ankylosing Spondylitis (Correct):** The 90% association is a diagnostic hallmark. While HLA-B27 is present in only 8% of the general population, its presence significantly increases the relative risk of developing AS [1]. * **Rheumatoid Arthritis:** This is primarily associated with **HLA-DR4** (specifically the "shared epitope"). It is not linked to HLA-B27. * **Psoriasis:** While Psoriatic Arthritis is part of the seronegative spondyloarthropathy group, the association with HLA-B27 is much lower (around 40-50%). Psoriasis itself is more strongly linked to **HLA-Cw6**. * **Reiter’s Syndrome (Reactive Arthritis):** This condition is also associated with HLA-B27, but the prevalence is lower than in AS, typically ranging from **60% to 80%**. **Clinical Pearls for NEET-PG:** 1. **Seronegative Spondyloarthropathies (PEAR):** Remember the mnemonic **P**soriatic arthritis, **E**nteropathic arthritis, **A**nkylosing spondylitis, and **R**eactive arthritis. All are associated with HLA-B27 and are Rheumatoid Factor (RF) negative [1]. 2. **Schober’s Test:** Used clinically to assess the restriction of lumbar flexion in AS. 3. **Other HLA Associations:** * HLA-B51: Behcet’s disease. * HLA-DQ2/DQ8: Celiac disease. * HLA-DR3/DR4: Type 1 Diabetes Mellitus.

Q: What pharmacokinetic change occurs in geriatric patients?

Renal clearance. The physiological process of aging leads to a progressive decline in the functional reserve of most organ systems [1]. In geriatric patients, the most significant and predictable pharmacokinetic change is a **reduction in renal clearance**. **1. Why Renal Clearance is the Correct Answer:** With advancing age, there is a physiological decrease in the number of functional nephrons, renal blood flow, and Glomerular Filtration Rate (GFR) [1]. Even in the absence of overt kidney disease, renal function can decline by approximately 1% per year after age 40. This leads to a prolonged half-life and increased plasma concentrations of drugs primarily excreted by the kidneys (e.g., Digoxin, Gentamicin, Lithium), necessitating dose adjustments to avoid toxicity. **2. Analysis of Incorrect Options:** * **A. Gastric Absorption:** While aging causes increased gastric pH and delayed gastric emptying, the overall *extent* of drug absorption (bioavailability) remains largely unchanged for most drugs. * **B. Liver Metabolism:** Hepatic blood flow and mass decrease with age, affecting the "first-pass" metabolism of some drugs. However, Phase II reactions (conjugation) remain relatively preserved, making liver metabolism less predictably altered than renal clearance. * **D. Hypersensitivity:** This is a pharmacodynamic or idiosyncratic reaction rather than a standard pharmacokinetic parameter (ADME). **3. NEET-PG High-Yield Pearls:** * **Cockcroft-Gault Formula:** Always use this to estimate CrCl in elderly patients, as serum creatinine alone may appear normal due to decreased muscle mass (sarcopenia) [1]. * **Vd Changes:** Elderly patients have increased body fat and decreased total body water. This **increases the Volume of Distribution (Vd)** for lipid-soluble drugs (e.g., Diazepam) and **decreases Vd** for water-soluble drugs (e.g., Digoxin). * **Rule of Thumb:** "Start low and go slow" is the clinical mantra for geriatric prescribing.

Q: What is the half-life of Factor VIII?

8 hours. **Explanation:** The correct answer is **8 hours**. Factor VIII (Anti-Hemophilic Factor) is a critical cofactor in the intrinsic pathway of the coagulation cascade. In the plasma, Factor VIII circulates bound to **von Willebrand Factor (vWF)**, which stabilizes it and protects it from rapid proteolytic degradation. * **Why 8 hours is correct:** The biological half-life of infused Factor VIII in patients with Hemophilia A typically ranges from **8 to 12 hours** [1]. For NEET-PG purposes, 8 hours is the standard "lower limit" value often tested. This relatively short half-life necessitates twice-daily dosing (every 12 hours) during acute bleeding episodes or major surgery to maintain therapeutic levels above 30-50%. **Analysis of Incorrect Options:** * **A (4 hours):** This is too short for Factor VIII. However, **Factor VII** has the shortest half-life of all clotting factors (approx. 4–6 hours), which is a frequent high-yield comparison. * **C (24 hours):** This is too long for Factor VIII. Factors like Prothrombin (Factor II) have a longer half-life (approx. 60–72 hours). * **D (30 hours):** This does not correspond to Factor VIII. Fibrinogen (Factor I) has a much longer half-life of about 3–5 days. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest Half-life:** Factor VII (4–6 hours). This is why the PT/INR rises first in liver failure or Vitamin K deficiency. * **Longest Half-life:** Factor II (Prothrombin). * **Hemophilia A:** X-linked recessive deficiency of Factor VIII [1]. * **Cryoprecipitate:** Contains Factor VIII, Fibrinogen, vWF, and Factor XIII. * **Desmopressin (DDAVP):** Used in mild Hemophilia A as it releases stored Factor VIII and vWF from endothelial Weibel-Palade bodies [2].

Q: Pharmacodynamics includes which of the following?

Mechanism of action. **Explanation:** Pharmacology is broadly divided into two main branches: **Pharmacokinetics** and **Pharmacodynamics**. **Why the correct answer is right:** **Pharmacodynamics** is defined as "what the drug does to the body." It focuses on the biochemical and physiological effects of drugs and their **mechanism of action**. This includes drug-receptor interactions, dose-response relationships, and the sequence of events leading to a therapeutic or toxic effect. Since "Mechanism of action" describes how a drug produces its effect at the cellular or molecular level, it falls squarely under pharmacodynamics. **Why the incorrect options are wrong:** Options A, B, and C (Elimination, Excretion, and Absorption) are components of **Pharmacokinetics**. Pharmacokinetics is "what the body does to the drug." It is traditionally remembered by the mnemonic **ADME**: * **Absorption:** Movement of the drug from the site of administration to the bloodstream. * **Distribution:** Movement of the drug from the blood to various tissues. * **Metabolism:** Biotransformation of the drug (primarily in the liver). * **Excretion/Elimination:** Removal of the drug or its metabolites from the body (primarily via kidneys). **High-Yield NEET-PG Pearls:** * **Pharmacodynamics** = **D**rug → Body (Effect/Mechanism). * **Pharmacokinetics** = **B**ody → Drug (ADME). * **Receptors** are the most common targets for pharmacodynamic action. * **Therapeutic Index (TI):** A key pharmacodynamic parameter calculated as $LD_{50} / ED_{50}$, representing the safety margin of a drug. * **Bioavailability:** A key pharmacokinetic parameter representing the fraction of an administered drug that reaches systemic circulation unchanged.

Question 1

In Prader-Willi syndrome, which of the following is increased?

Accepted Answer

Ghrelin

Answer

LH

Answer

FSH

Answer

TSH

Question 2

Haversian system is seen in which type of bone tissue?

Accepted Answer

Cortical bone

Answer

Cancellous bone

Answer

Teeth

Answer

Nail

Question 3

Which of the following is NOT a cyanotic heart disease?

Accepted Answer

Patent Ductus Arteriosus (PDA)

Answer

Tetralogy of Fallot (TOF)

Answer

Tricuspid atresia

Answer

Eisenmenger's complex

Question 4

Phase 2 of damage control surgery typically occurs during which phase of patient management?

Accepted Answer

Resuscitation in the ICU

Answer

Pre-hospital management

Answer

Resuscitation in the operating room

Answer

Definitive repair

Question 5

Which of the following is NOT a component of the acute inflammatory response?

Accepted Answer

Granuloma formation

Answer

Vasodilation

Answer

Exudation

Answer

Neutrophilic response

Question 6

Memory T cells can be identified by using which of the following markers?

Accepted Answer

CD45RO

Answer

CD 45RA

Answer

CD45RB

Answer

CD45RC

Question 7

Which of the following conditions is associated with HLA-B27 in 90% of cases?

Accepted Answer

Ankylosing spondylitis

Answer

Rheumatoid arthritis

Answer

Psoriasis

Answer

Reiter's syndrome

Question 8

What pharmacokinetic change occurs in geriatric patients?

Accepted Answer

Renal clearance

Answer

Gastric absorption

Answer

Liver metabolism

Answer

Hypersensitivity

Question 9

What is the half-life of Factor VIII?

Accepted Answer

8 hours

Answer

4 hours

Answer

24 hours

Answer

30 hours

Question 10

Pharmacodynamics includes which of the following?

Accepted Answer

Mechanism of action

Answer

Drug Elimination

Answer

Drug Excretion

Answer

Drug Absorption

Neuroanatomy — MCQs

Neuroanatomy — MCQs

On this page

Practice by Chapter

Want unlimited practice?